Acyclic retinoid combined with Tenascin-C-derived peptide reduces the malignant phenotype of neuroblastoma cells through N-Myc degradation.

Otsuka K, Sasada M, Hirano Y, Nohara Y, Iyoda T, Higami Y, Kodama H, Fukai F

Anticancer Res.

2019-07

39

7

3487

ENG

3492

学術論文